EW
OGN icon

Evoke Wealth’s Organon & Co OGN Stock Holding History

Evoke Wealth’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-235
Closed -$5K – 883
2022
Q3 		$5K Sell
235
-139
-37% -$4.2K ﹤0.01% 885
2022
Q2 		$13K Sell
374
-155
-29% -$5.43K ﹤0.01% 733
2022
Q1 		$18K Buy
529
+12
+2% +$410 ﹤0.01% 676
2021
Q4 		$16K Buy
517
+1
+0.2% +$33 ﹤0.01% 716
2021
Q3 		$16K Sell
516
-222
-30% -$7.1K ﹤0.01% 671
2021
Q2 		$19K Buy
+738
New +$24.3K ﹤0.01% 663

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Evoke Wealth's OGN Position: Q4 2022 in Review

Evoke Wealth sold out of Organon & Co (OGN) in Q4 2022, closing a stake of 235 shares — an estimated $5K sold.

Evoke Wealth first reported a position in OGN in Q2 2021 and held it in 6 quarters. The position peaked at $19K in Q2 2021. 821 funds tracked by Wall St. Rank hold OGN as of Q4 2022.

  • Evoke Wealth reported no remaining Organon & Co position as of Q4 2022 after selling out during the quarter.
  • Evoke Wealth sold 235 Organon & Co shares in Q4 2022, an estimated $5K.
  • Evoke Wealth first reported a position in Organon & Co in Q2 2021 and held it in 6 quarters.
  • Evoke Wealth's Organon & Co position peaked at $19K in Q2 2021.
  • 821 funds tracked by Wall St. Rank held Organon & Co as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.